SLC7A11 is a potential therapeutic target and prognostic biomarker correlated with immune cell infiltration in cervical cancer
SLC7A11, correlated with immune pathway, is a risk factor affecting the prognosis of cervical cancer. We also explore 37 kinds of drugs that may benefit cervical cancer patients.
Authors
- Tingting Bian (ORCID: https://orcid.org/0000-0001-5577-9216)
- Yiping Hao (ORCID: https://orcid.org/0000-0002-3515-9527)
- Baoxia Cui (ORCID: https://orcid.org/0009-0002-1721-4155)
- Wenjing Zhang (ORCID: https://orcid.org/0000-0002-4507-5351)
- Lingwei Sun (ORCID: https://orcid.org/0000-0002-3438-6584)
- Xinlin Jiao
- Mutangala Muloye Guy (ORCID: https://orcid.org/0009-0008-7240-7404)
- Teng Zhang (ORCID: https://orcid.org/0000-0002-7729-8023)
Institutions
- University of Lubumbashi (CD)
- Qilu Hospital of Shandong University (CN)
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1007/s12672-025-01888-7
- Citations
- 8
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 12.15
Funders
- National Natural Science Foundation of China